Nemera

Activities: Drug Delivery Medical Devices Pharmaceutical

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    AstraZeneca resumes £300m UK investment as drug pricing and tariff landscape shifts The Cambridge and Macclesfield programmes, paused amid NHS reimbursement disputes, are back on track following the US-UK pharmaceutical deal and a revised NHS rebate rate
  3. BASF reports Q1 earnings as currency headwinds and Middle East conflict weigh on revenue The German chemicals giant posted solid volume growth across most segments in the first quarter of 2026, but adverse currency effects eroded sales and pushed EBITDA before...
  4. MHRA report shows agency met targets and closed year in financial surplus The UK government agency has reported meeting or exceeding every statutory performance target in the 2025/26 financial year, closing in financial surplus while advancing...
  5. DINAMIQS secures Swissmedic licence for viral vector GMP manufacturing at Zurich facility Siegfried-owned DINAMIQS has gained Swissmedic approval to manufacture and release ATMPs, establishing itself as Switzerland’s first fully integrated viral vector CDMO with...

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

Related Content

Manufacturing

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Finished Product

Nemera’s Novelia preservative-free multi-dose eyedropper approved in China

Nemera’s Novelia multi-dose eyedropper has been approved in China through a partnership with Haohai Qisheng, supporting the launch of the company's preservative-free lubricant eye drop

Nemera expands production capacity in Szczecin to strengthen leadership in GLP-1 drug market

Nemera, a global leader in the design, development and manufacturing of drug delivery device solutions, has  inaugurated a new production hall at its facility in Szczecin, Poland
Packaging

Nemera's UniSpray compatible with Nipro's unit-dose microvials

Nipro PharmaPackaging and Nemera announce the successful compatibility testing of Nemera’s UniSpray and Nipro’s unit-doseTM microvials
Drug Delivery

Cristalia products with Nemera’s reusable pen injector commercialised in Brazil

Cristalia’s human growth hormone will be administered with CRISPEN, a pen injector designed by Nemera
Manufacturing

Nemera extends manufacturing capabilities in North America

With a newly acquired space in Vernon Hills, Nemera has opened a third location in the US, in addition to the manufacturing facility in Buffalo Grove and Innovation Center in Chicago
Manufacturing

Nemera's manufacturing facility inaugurated in Poland

The total area of the new site covers over 11,000 square metres including a 3,400 square metres clean room space
Subscribe now